Stryker Corporation $SYK Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC decreased its stake in shares of Stryker Corporation (NYSE:SYK) by 5.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,958,916 shares of the medical technology company’s stock after selling 116,420 shares during the quarter. Janus Henderson Group PLC’s holdings in Stryker were worth $643,677,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of SYK. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker during the fourth quarter worth about $26,000. Sankala Group LLC acquired a new stake in Stryker in the fourth quarter valued at approximately $26,000. United Financial Planning Group LLC purchased a new position in Stryker in the third quarter worth approximately $27,000. Atlas Capital Advisors Inc. purchased a new position in Stryker in the fourth quarter worth approximately $27,000. Finally, DJE Kapital AG acquired a new position in Stryker during the 4th quarter worth approximately $28,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insiders Place Their Bets

In other news, VP Robert S. Fletcher sold 4,544 shares of Stryker stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the sale, the vice president owned 10,582 shares in the company, valued at approximately $3,247,298.34. The trade was a 30.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the company’s stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares of the company’s stock, valued at approximately $601,005,282.40. This trade represents a 13.87% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 323,264 shares of company stock valued at $100,659,489. 4.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have commented on SYK. Wells Fargo & Company dropped their price objective on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Evercore set a $350.00 target price on shares of Stryker in a research note on Monday, July 6th. Argus set a $370.00 target price on Stryker in a report on Thursday, July 9th. Wall Street Zen cut Stryker from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, JPMorgan Chase & Co. decreased their price target on Stryker from $445.00 to $400.00 and set an “overweight” rating for the company in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $393.39.

Stryker Stock Up 1.7%

SYK stock opened at $352.35 on Thursday. The stock has a market cap of $135.08 billion, a P/E ratio of 40.78, a PEG ratio of 2.22 and a beta of 0.77. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $403.22. The company’s 50 day moving average is $316.38 and its two-hundred day moving average is $335.11.

Stryker (NYSE:SYK) last issued its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). The company had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.84 EPS. Research analysts expect that Stryker Corporation will post 14.99 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, June 30th. Stryker’s dividend payout ratio is currently 40.74%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.